111 related articles for article (PubMed ID: 8095860)
1. Discussion: the Satellite Symposium on "Ifosfamide in the treatment of sarcomas" of the 6th European Conference on Clinical Oncology and Cancer Nursing, Firenze, October 27, 1991.
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S244-9. PubMed ID: 8095860
[No Abstract] [Full Text] [Related]
2. Ifosfamide in gynecological tumors. Satellite symposium of 5th European Conference on Clinical Oncology and Cancer Nursing. London, September 3-7, 1989. Proceedings.
Cancer Chemother Pharmacol; 1990; 26 Suppl():S1-102. PubMed ID: 2347044
[No Abstract] [Full Text] [Related]
3. The role of ifosfamide in the treatment of sarcomas.
Dirix LY; Van Oosterom AT
Semin Oncol; 1989 Feb; 16(1 Suppl 3):39-45. PubMed ID: 2649984
[TBL] [Abstract][Full Text] [Related]
4. The role of ifosfamide in the treatment of adult soft tissue sarcomas, Ewing's sarcoma, and osteosarcoma: a review.
Dirix LY; Van Oosterom AT
Semin Oncol; 1990 Apr; 17(2 Suppl 4):50-7. PubMed ID: 2185547
[TBL] [Abstract][Full Text] [Related]
5. Recent experience with ifosfamide/mesna in solid tumors. International satellite symposium to the 3rd European Conference on Clinical Oncology. Stockholm, June 1985. Proceedings.
Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S1-58. PubMed ID: 3102087
[No Abstract] [Full Text] [Related]
6. Current developments and future direction with ifosfamide. Proceedings of a satellite symposium of the European Society of Medical Oncology. October 31, 1988, Lugano, Switzerland.
Semin Oncol; 1989 Feb; 16(1 Suppl 3):1-101. PubMed ID: 2704999
[No Abstract] [Full Text] [Related]
7. Ifosfamide in the treatment of soft tissue sarcomas.
Connelly EF; Budd GT
Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
[TBL] [Abstract][Full Text] [Related]
9. High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone.
Demetri GD
Semin Oncol; 1996 Jun; 23(3 Suppl 6):22-6. PubMed ID: 8677444
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group.
Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verweij J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S180-4. PubMed ID: 8453694
[TBL] [Abstract][Full Text] [Related]
11. High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas.
Yalcin B; Pamir A; Buyukcelik A; Utkan G; Akbulut H; Demirkazik A; Icli F
Exp Oncol; 2004 Dec; 26(4):320-5. PubMed ID: 15627067
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide with regional hyperthermia in soft-tissue sarcomas.
Schlemmer M; Wendtner CM; Issels RD
Oncology; 2003; 65 Suppl 2():76-9. PubMed ID: 14586154
[TBL] [Abstract][Full Text] [Related]
13. Gynecologic Oncology Group studies with ifosfamide.
Sutton GP; Blessing JA; Manetta A; Homesley H; McGuire W
Semin Oncol; 1992 Dec; 19(6 Suppl 12):31-4. PubMed ID: 1485172
[TBL] [Abstract][Full Text] [Related]
14. Ifosfamide in the adjuvant therapy of soft tissue sarcomas.
Frustaci S; De Paoli A; Bidoli E; La Mura N; Berretta M; Buonadonna A; Boz G; Gherlinzoni F
Oncology; 2003; 65 Suppl 2():80-4. PubMed ID: 14586155
[TBL] [Abstract][Full Text] [Related]
15. Current developments and future directions with ifosfamide: an update. Proceedings of a satellite symposium of the XV Congress of the European Society for Medical Oncology. Copenhagen, Denmark, December 2, 1990.
Semin Oncol; 1992 Feb; 19(1 Suppl 1):1-77. PubMed ID: 1357753
[No Abstract] [Full Text] [Related]
16. Ifosfamide in the treatment of pediatric malignancies. 4th European Conference on Clinical Oncology and Cancer Nursing. Madrid, November 1987. Proceedings.
Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S1-51. PubMed ID: 2758565
[No Abstract] [Full Text] [Related]
17. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
Antman K; Crowley J; Balcerzak SP; Rivkin SE; Weiss GR; Elias A; Natale RB; Cooper RM; Barlogie B; Trump DL
J Clin Oncol; 1993 Jul; 11(7):1276-85. PubMed ID: 8315425
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide in the treatment of malignant epithelial ovarian tumors.
Lissoni AA; Fei F; Rossi R; Fruscio R; Villa A; Zani G
Oncology; 2003; 65 Suppl 2():59-62. PubMed ID: 14586150
[TBL] [Abstract][Full Text] [Related]
19. Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group.
Blackledge G; Steward WP; Verweij J; Mouridsen H; Bramwell V; Schütte J; van Oosterom A; Dombernowsky P; Buesa J; Van Glabekke M
Semin Oncol; 1992 Feb; 19(1 Suppl 1):14-8. PubMed ID: 1411615
[TBL] [Abstract][Full Text] [Related]
20. Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience.
Benjamin RS; Legha SS; Patel SR; Nicaise C
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S174-9. PubMed ID: 8453693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
